Corporate News     25-Apr-24 Divi's Laboratories plans capacity addition with investment of up to Rs 700 cr Divi's Laboratories is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment between Rs 650 crore to Rs 700 crore, to be funded from internal accruals. The proposed facility is expected to be operational around January, 2027. Previous News   Divis Laboratories fixes record date for dividend  ( Market Beat - Reports 04-Jul-22   19:18 )   Divis Laboratories Ltd spurts 1.23%, gains for five straight sessions  ( Hot Pursuit - 31-Dec-21   13:00 )   Divi’s Labs PAT soars 47% YoY to Rs 510 crore in Q2  ( Hot Pursuit - 09-Nov-24   16:09 )   Divis Labs gets GST demand notice of Rs 164 cr  ( Hot Pursuit - 16-Nov-23   15:38 )   Marksans Pharma Ltd Slips 4.87%  ( Hot Pursuit - 08-Jun-20   09:45 )   Divis Laboratories Ltd rises for third straight session  ( Hot Pursuit - 17-Nov-23   13:05 )   Divi's Laboratories consolidated net profit rises 16.72% in the September 2021 quarter  ( Results - Announcements 06-Nov-21   13:04 )   Divis Laboratories Ltd spurts 0.27%, gains for fifth straight session  ( Hot Pursuit - 24-Jun-22   13:00 )   Divis Lab spurts after strong Q1 performance  ( Hot Pursuit - 10-Aug-20   09:29 )   Divis Laboratories Ltd soars 1.13%, up for fifth straight session  ( Hot Pursuit - 04-Apr-24   13:00 )   Divis Laboratories Ltd soars 1.51%, up for third straight session  ( Hot Pursuit - 02-Apr-24   13:05 )	Other Stories   Mercury Trade Links to conduct EGM   15-Mar-25   20:06   Galada Finance to conduct board meeting   15-Mar-25   20:06   Board of Galaxy Surfactants recommends interim dividend   15-Mar-25   16:12   Heads UP Ventures announces board meeting date   15-Mar-25   16:12   Savera Industries to conduct board meeting   15-Mar-25   16:12   Strides Pharma Science announces acquisition of Singapore-based Amexel   15-Mar-25   15:45   Mphasis allots 99,115 equity shares under ESOP   15-Mar-25   15:43   Shilpa Pharma Lifesciences' Unit-2 clear USFDA inspection   15-Mar-25   15:40   Wipro grants 9,868 RSUs under ESOP   15-Mar-25   15:39   New Delhi Television announces resignation of director   15-Mar-25   15:38
Back Top